相似化合物
53981-25-2 364-31-8 82419-26-9欧盟法规
ECHA物质C&L通报REACH预注册上下游产品
CAS号367-12-4 2-氟苯酚 | CAS号7440-44-0 活性炭 | CAS号402-67-5 间氟硝基苯 | CAS号394-50-3 3-氟水杨醛 | CAS号437-83-2 3-氟-2-甲氧基苯胺 | CAS号35048-10-3 7-氟-8-羟基喹啉 | CAS号484-94-6 2-氟-6-硝基苯甲醚 | CAS号194804-99-4 3-(4-溴-2-氟-3-甲氧... | CAS号845829-94-9 2-溴-6-氟苯甲醚 | CAS号74266-68-5 3-氟-2-甲氧基苯甲醛 | CAS号53981-25-2 6-氟-2-氨基苯酚 | CAS号194804-92-7 4-溴-2-氟-3-甲氧基苯甲酸 | CAS号898832-40-1 8-氟-3,4-二氢-2H-苯...2-氟苯酚置于三氯异氰尿酸,Bismuth Subnitrate/charcoal体系中,用 二氯甲烷 用作溶剂,化学反应 1.0H,以85%的收率获得2-氟-6-硝基苯酚
参考文献:在非质子条件下在三氯异氰尿酸存在下使用亚硝酸铋/木炭选择性硝化苯酚
标题:在非质子条件下在三氯异氰尿酸存在下使用亚硝酸铋/木炭选择性硝化苯酚
摘要:摘要描述了一种在室温下在ch2Cl2中存在三氯异氰尿酸的情况下使用亚硝酸铋/木炭温和,高效且区域选择性的方法,用于酚类化合物的单硝化.
Doi:10.1016/j.Cclet.2010.05.016
海关参考信息
- 2908199090-其他酚的卤化衍生物
2908999090-其他酚的硝化衍生物
2918290000-其他含酚基羧酸
2905199090-其他饱和一元醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2016194279-A1
优先权日:2012-12-09
标 题 :One pot process for the conversion of aroyl chlorides to acyl thioureas
发明人:CHEPURI VENKATA RAMANA; BEERAN SENTHILKUMAR
权利人:COUNCIL SCIENT IND RES
摘要:The present invention disclose an improved one pot process for synthesis of acyl thioureas of formula (I), with yield greater than 80%, from aroyl chlorides of formula (I) wherein, R′ is an aryl or a heteroarylene group substituted with one or more groups selected from hydrogen, alkyl, alkylene, alkynyl, alkoxy, alkenyloxy, halo, hydroxyl, nitro, amino, carboxyl, ester, halogenated hydrocarbon or an aryl or heteroaryl; R″ and R′″ are selected independently from hydrogen, alkyl, alkylene, alkynyl, alkoxy, alkenyloxy, halo, hydroxyl, nitro, amino or halogenated hydrocarbon.
专利号:US-9096624-B2
优先权日:2009-06-01
标 题:Amino pyrimidine anticancer compounds
发明人:CREW ANDREW P; SHERMAN DAN; APPARI RAMA DEVI; CHEN XIN; CHILUKURI RAMESH; DONG HANQING; FERRARO CATERINA; FOREMAN KENNETH; GUPTA RAMESH C; LI AN-HU; STOLZ KATHRYN M; VOLK BRIAN; ZAHLER ROBERT
权利人:OSI PHARMACEUTICALS LLC
摘要:Compounds of Formula 1, as shown below and defined herein: n n n n n n n n n n n n and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by FAK.